Selected article for: "common cold and coronavirus influenza"

Author: Schmidt, Megan E.; Varga, Steven M.
Title: The CD8 T Cell Response to Respiratory Virus Infections
  • Cord-id: p7rvupjo
  • Document date: 2018_4_9
  • ID: p7rvupjo
    Snippet: Humans are highly susceptible to infection with respiratory viruses including respiratory syncytial virus (RSV), influenza virus, human metapneumovirus, rhinovirus, coronavirus, and parainfluenza virus. While some viruses simply cause symptoms of the common cold, many respiratory viruses induce severe bronchiolitis, pneumonia, and even death following infection. Despite the immense clinical burden, the majority of the most common pulmonary viruses lack long-lasting efficacious vaccines. Nearly a
    Document: Humans are highly susceptible to infection with respiratory viruses including respiratory syncytial virus (RSV), influenza virus, human metapneumovirus, rhinovirus, coronavirus, and parainfluenza virus. While some viruses simply cause symptoms of the common cold, many respiratory viruses induce severe bronchiolitis, pneumonia, and even death following infection. Despite the immense clinical burden, the majority of the most common pulmonary viruses lack long-lasting efficacious vaccines. Nearly all current vaccination strategies are designed to elicit broadly neutralizing antibodies, which prevent severe disease following a subsequent infection. However, the mucosal antibody response to many respiratory viruses is not long-lasting and declines with age. CD8 T cells are critical for mediating clearance following many acute viral infections in the lung. In addition, memory CD8 T cells are capable of providing protection against secondary infections. Therefore, the combined induction of virus-specific CD8 T cells and antibodies may provide optimal protective immunity. Herein, we review the current literature on CD8 T cell responses induced by respiratory virus infections. Additionally, we explore how this knowledge could be utilized in the development of future vaccines against respiratory viruses, with a special emphasis on RSV vaccination.

    Search related documents:
    Co phrase search for related documents
    • activation marker and acute respiratory infection: 1, 2, 3, 4, 5, 6, 7
    • activation marker and acute respiratory infection disease: 1, 2
    • activation marker and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • activation marker and acute viral infection: 1
    • activation marker and adaptive immune response: 1
    • acute infection and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute infection and additional population: 1, 2, 3
    • acute infection and adoptive transfer: 1, 2, 3, 4, 5, 6
    • acute infection and local immunization: 1
    • acute respiratory infection and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute respiratory infection and additional population: 1, 2
    • acute respiratory infection disease and adaptive immune response: 1
    • acute respiratory infection disease and additional population: 1
    • acute respiratory syndrome and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome and additional population: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
    • acute respiratory syndrome and adoptive transfer: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute respiratory virus infection and adaptive immune response: 1
    • acute rsv infection and adaptive immune response: 1
    • acute viral infection and adaptive immune response: 1, 2, 3, 4